The short answer
The EU leans toward precaution: it classifies carcinogens by hazard and can phase out the worst under unified EU-wide laws. The US leans toward risk assessment, spread across agencies like the EPA, OSHA, FDA, and NTP. Each approach has strengths and trade-offs.
The EU uses unified, largely hazard-based frameworks (CLP, REACH, the workplace directive).
The US uses risk-based, agency-specific approaches (EPA, OSHA, FDA, NTP).
The EU can more readily phase out substances based on hazard.
The US often requires risk estimates before acting, which can be slower but more targeted.
Choose how you want to understand this
The full explanation.
Two philosophies, one goal
The European Union and the United States both work to protect people from cancer-causing substances. They tend to go about it differently. Seeing the contrast explains why the same chemical can be handled one way in Europe and another way in America, and why neither side is simply "right." This is a comparison of general tendencies. Both systems borrow from each other.
The EU: precaution and hazard
The EU's frameworks are CLP, REACH, and the workplace directive. They lean toward precaution and hazard-based classification:
- A substance is classified largely by its built-in hazard. The question is whether it can cause cancer at all.
- That classification can trigger action, such as SVHC listing, authorisation, or restriction. The aim is to phase out the worst substances and push toward safer ones.
- The rules are unified across the EU and apply the same way in every member state.
Strength: the EU can act on a hazard fairly quickly, without a full real-world risk calculation for every use. Trade-off: it may restrict substances that pose little risk at the levels people actually meet.
The US: risk and agencies
The US leans toward risk assessment, spread across several agencies, each with its own remit:
- The EPA assesses environmental chemicals through IRIS and sets standards for air, water, and cleanup. It often estimates how much exposure causes how much risk.
- OSHA sets workplace exposure limits.
- The FDA regulates food, drugs, and cosmetics.
- The NTP publishes the Report on Carcinogens, which identifies hazards.
There is no single US chemicals law to match REACH. Action often calls for an estimate of real-world risk before a substance is restricted.
Strength: decisions can be targeted to actual risk. Trade-off: the process can be slower and more scattered, and gaps can open between agencies.
Why they sometimes disagree
The clearest example is glyphosate. IARC, the World Health Organization's cancer agency, took a hazard-focused view and called it "probably carcinogenic to humans." The US EPA ran a risk-based review and concluded that glyphosate is "not likely to be carcinogenic to humans." Same chemical, different frameworks, different conclusions. It is a direct product of the hazard-versus-risk distinction.
California's Proposition 65 is an interesting case. It is a hazard-based system running inside a country that mostly works from risk. That is part of why it stands out, and part of why it draws criticism.
Neither is simply 'better'
It is tempting to crown a winner. But these are real trade-offs, and reasonable people weigh them differently:
- Precaution (EU) guards against uncertain hazards sooner. The cost is sometimes over-restricting.
- Risk-based precision (US) aims action at real-world risk. The cost is acting later and less evenly.
Both aim to protect health. They differ mainly in how they balance caution against precision when the science is unsettled.
The bottom line
The EU regulates carcinogens through unified, precautionary, hazard-based frameworks that can phase out the worst substances. The US relies more on risk-based, agency-specific assessment. Each has real strengths and real trade-offs. The difference between them is, at heart, one more expression of hazard versus risk.
Sources
Words to know
Tap any term to see what it means.
Common questions
How do the EU and US approaches differ?
The EU leans on precaution and hazard-based classification through unified laws (CLP, REACH, the workplace directive), and can move to phase out the worst substances. The US relies more on risk-based assessment spread across several agencies (EPA, OSHA, FDA, NTP), often requiring risk estimates before acting.
Which approach is better?
Neither is simply 'better' — they involve trade-offs. The EU's precaution can act faster on hazards but may restrict substances that pose little real-world risk. The US's risk-based style can be more targeted but slower and more fragmented.
Do they ever reach different conclusions?
Yes. Glyphosate is a famous example: hazard-focused and risk-focused assessments led to different regulatory responses. The difference often reflects hazard-versus-risk framing.
Is one system hazard-based and the other risk-based?
As a broad generalization, yes — the EU emphasizes hazard and precaution, the US emphasizes risk assessment. But both use elements of each, so the contrast is a matter of emphasis.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 4 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-11 what this meansLast updated: 2026-08-11Next planned review: 2028-07-05
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share